False-Positive Ketamine Drug Screens: Medication Cross-Reactivity, Not Food or Drink
No foods or drinks are documented to cause false-positive ketamine results on drug screening; however, certain medications—particularly quetiapine—can trigger false-positive ketamine immunoassays that require confirmatory testing to resolve. 1
Medication-Induced False Positives
The primary concern with ketamine screening is medication cross-reactivity, not dietary substances:
Quetiapine (an atypical antipsychotic) is the most clearly documented medication that produces false-positive ketamine immunoassay results, as demonstrated in case reports where confirmation testing ultimately proved the results were spurious. 1
Standard immunoassay screening tests for ketamine are susceptible to cross-reactions with structurally similar compounds, which limits their specificity despite good sensitivity. 2
False-positive results from immunoassays represent a screening artifact rather than true drug detection, underscoring why positive screens should never be considered definitive without confirmation. 2
The Critical Role of Confirmatory Testing
Any positive ketamine immunoassay must be confirmed with gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) before clinical or legal decisions are made:
Confirmatory testing can positively identify the specific substance and generate quantitative concentrations, eliminating false-positive results from cross-reactive medications. 2
The two-step approach (screening followed by confirmation of positives only) is standard practice, though some laboratories now perform confirmatory testing more broadly as costs have decreased. 2
A positive immunoassay result in a patient taking quetiapine or other potentially cross-reactive medications should prompt immediate confirmatory testing rather than assumption of ketamine use. 1, 3
Clinical Context and Interpretation
Drug test results must always be interpreted within the full clinical picture:
Pretest probability matters: A positive ketamine screen is more likely to be a true positive when clinical findings (toxidrome, altered mental status, history) suggest ketamine exposure. 2
In the absence of supporting clinical evidence or known ketamine exposure, a positive screen in a patient on quetiapine or similar medications should be presumed false until proven otherwise. 1
Clinicians should obtain a complete medication list—including over-the-counter agents—before ordering drug screens, as multiple medication classes beyond quetiapine have been reported to cause false positives for other drug classes. 4, 5, 6
Common Pitfalls to Avoid
Never act on immunoassay results alone for ketamine when the clinical scenario doesn't fit or when the patient is taking potentially cross-reactive medications. 2, 1
Do not assume that a negative screen rules out ketamine use if clinical suspicion is high; immunoassays have detection windows and cutoff thresholds that may miss recent or low-level use. 2
Avoid conflating false-positive results with patient dishonesty; medication interference is a known limitation of immunoassay technology and should be explained to patients and families. 3
No Evidence for Food or Beverage Interference
The published literature on false-positive drug screens—including comprehensive reviews spanning amphetamines, opiates, benzodiazepines, cannabinoids, and other drug classes—does not identify any foods or beverages that cause false-positive ketamine results. 4, 5, 6 Cross-reactivity is consistently attributed to medications with structural similarity to the target analyte, not dietary substances.